Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamer Aboushwareb

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
BJU International|February 1, 2017
Positive outcomes with first onabotulinumtoxinA treatment persist in the long term with repeat treatments in patients with neurogenic detrusor overactivityPierre Denys, Roger Dmochowski, Philip Aliotta, et al.
Biomaterials|July 31, 2012
Decellularization methods of porcine kidneys for whole organ engineering using a high-throughput systemDavid C Sullivan, Sayed-Hadi Mirmalek-Sani, Daniel B Deegan, et al.
World Journal of Urology|November 13, 2013
Adipose-derived stem cells (ADSCs) and muscle precursor cells (MPCs) for the treatment of bladder voiding dysfunctionMathias Tremp, Souzan Salemi, Remo Largo, et al.
Plos One|September 1, 2022
The 17-gene Genomic Prostate Score assay as a predictor of biochemical recurrence in men with intermediate and high-risk prostate cancerBrian T Helfand, Michael Paterakos, Chi-Hsiung Wang, et al.
Current Medical Research and Opinion|February 21, 2018
Clean intermittent catheterization rates after initial and subsequent treatments with onabotulinumtoxinA for non-neurogenic overactive bladder in real-world clinical settingsMichael Kennelly, Lonny Green, Nancy Alvandi, et al.
Stem Cells Translational Medicine|December 1, 2012
Cell therapy with human renal cell cultures containing erythropoietin-positive cells improves chronic kidney injuryLiliya M Yamaleyeva, Nadia K Guimaraes-Souza, Louis S Krane, et al.
Acta Biomaterialia|November 25, 2015
Repopulation of porcine kidney scaffold using porcine primary renal cellsMehran Abolbashari, Sigrid M Agcaoili, Mi-Kyung Lee, et al.
JCO Precision Oncology|May 26, 2021
GPS Assay Association With Long-Term Cancer Outcomes: Twenty-Year Risk of Distant Metastasis and Prostate Cancer-Specific MortalityMichael A Brooks, Lewis Thomas, Cristina Magi-Galluzzi, et al.
Urologic Oncology|November 26, 2021
Validating the association of adverse pathology with distant metastasis and prostate cancer mortality 20-years after radical prostatectomyMichael A Brooks, Lewis Thomas, Cristina Magi-Galluzzi, et al.
The Journal of Urology|March 22, 2008
Voiding pattern analysis as a surrogate for cystometric evaluation in uroplakin II knockout miceSteve J Hodges, Ge Zhou, Fang-Ming Deng, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
BJU International|February 1, 2017
Positive outcomes with first onabotulinumtoxinA treatment persist in the long term with repeat treatments in patients with neurogenic detrusor overactivityPierre Denys, Roger Dmochowski, Philip Aliotta, et al.
Biomaterials|July 31, 2012
Decellularization methods of porcine kidneys for whole organ engineering using a high-throughput systemDavid C Sullivan, Sayed-Hadi Mirmalek-Sani, Daniel B Deegan, et al.
World Journal of Urology|November 13, 2013
Adipose-derived stem cells (ADSCs) and muscle precursor cells (MPCs) for the treatment of bladder voiding dysfunctionMathias Tremp, Souzan Salemi, Remo Largo, et al.
Plos One|September 1, 2022
The 17-gene Genomic Prostate Score assay as a predictor of biochemical recurrence in men with intermediate and high-risk prostate cancerBrian T Helfand, Michael Paterakos, Chi-Hsiung Wang, et al.
Current Medical Research and Opinion|February 21, 2018
Clean intermittent catheterization rates after initial and subsequent treatments with onabotulinumtoxinA for non-neurogenic overactive bladder in real-world clinical settingsMichael Kennelly, Lonny Green, Nancy Alvandi, et al.
Stem Cells Translational Medicine|December 1, 2012
Cell therapy with human renal cell cultures containing erythropoietin-positive cells improves chronic kidney injuryLiliya M Yamaleyeva, Nadia K Guimaraes-Souza, Louis S Krane, et al.
Acta Biomaterialia|November 25, 2015
Repopulation of porcine kidney scaffold using porcine primary renal cellsMehran Abolbashari, Sigrid M Agcaoili, Mi-Kyung Lee, et al.
JCO Precision Oncology|May 26, 2021
GPS Assay Association With Long-Term Cancer Outcomes: Twenty-Year Risk of Distant Metastasis and Prostate Cancer-Specific MortalityMichael A Brooks, Lewis Thomas, Cristina Magi-Galluzzi, et al.
Urologic Oncology|November 26, 2021
Validating the association of adverse pathology with distant metastasis and prostate cancer mortality 20-years after radical prostatectomyMichael A Brooks, Lewis Thomas, Cristina Magi-Galluzzi, et al.
The Journal of Urology|March 22, 2008
Voiding pattern analysis as a surrogate for cystometric evaluation in uroplakin II knockout miceSteve J Hodges, Ge Zhou, Fang-Ming Deng, et al.
Pageof 4